Press Releases

GI Dynamics, Inc. Announces Corporate Restructuring

LEXINGTON, Massachusetts & SYDNEY, Australia – 21 August 2015 – GI Dynamics, Inc. (ASX: GID) (GI Dynamics), a medical device company that provides innovative treatments for type 2 diabetes and obesity, today announced that it is reducing headcount by approximately 46% as part of its efforts to...

read more

Appendix 4C Quarterly Report Quarter Ended 30 June 2015

LEXINGTON, Massachusetts, United States and SYDNEY, Australia – 30 July 2015 – GI Dynamics, Inc. (ASX: GID) (GI Dynamics or the Company), a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced its financial results for the quarter ended 30 June...

read more

GI Dynamics Concludes ENDO Trial

A review of interim results to follow   Conference call at 9:00 a.m. AEST on 31 July 2015 (7:00 p.m. EDT on 30 July 2015) LEXINGTON, Massachusetts & SYDNEY, Australia – 30 July 2015 – GI Dynamics, Inc. (ASX: GID) (the Company), a medical device company that provides innovative treatments for...

read more

Appendix 4C Quarterly Report Quarter Ended 31 March 2015

LEXINGTON, Massachusetts, United States and SYDNEY, Australia–(BUSINESS WIRE)–GI Dynamics, Inc. (ASX: GID) (GI Dynamics or the Company), a medical device company developing innovative treatments for type 2 diabetes and obesity, is pleased to provide its financial results for the...

read more

ENDO Trial Placed on Enrollment Hold

LEXINGTON, Mass & SYDNEY–(BUSINESS WIRE)–GI Dynamics, Inc. (ASX: GID) (GI Dynamics or the Company), a medical device company developing innovative treatments for type 2 diabetes and obesity, announced today that the U.S. Food and Drug Administration (FDA) has placed a hold on...

read more

Appendix 4C Quarterly Report Quarter ended 31 December 2014

LEXINGTON, Massachusetts, United States and SYDNEY, Australia – 30 January 2015 – GI Dynamics, Inc. (ASX: GID) (GI Dynamics or the Company), a medical device company developing innovative treatments for type 2 diabetes and obesity, is pleased to provide its financial results for the quarter ended...

read more
Page 3 of 3123

Filter By Year